GBIO
Price
$0.37
Change
-$0.03 (-7.50%)
Updated
Apr 4, 02:36 PM (EDT)
Capitalization
26.64M
27 days until earnings call
GLSI
Price
$8.88
Change
-$0.37 (-4.00%)
Updated
Apr 4, 02:33 PM (EDT)
Capitalization
122.18M
45 days until earnings call
Ad is loading...

GBIO vs GLSI

Header iconGBIO vs GLSI Comparison
Open Charts GBIO vs GLSIBanner chart's image
Generation Bio
Price$0.37
Change-$0.03 (-7.50%)
Volume$300
Capitalization26.64M
Greenwich LifeSciences
Price$8.88
Change-$0.37 (-4.00%)
Volume$100
Capitalization122.18M
GBIO vs GLSI Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. GLSI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Hold and GLSI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GBIO: $0.40 vs. GLSI: $9.25)
Brand notoriety: GBIO and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 158% vs. GLSI: 528%
Market capitalization -- GBIO: $26.64M vs. GLSI: $122.18M
GBIO [@Biotechnology] is valued at $26.64M. GLSI’s [@Biotechnology] market capitalization is $122.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, GBIO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • GBIO’s TA Score: 4 bullish, 4 bearish.
  • GLSI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GBIO and GLSI are a good buy in the short-term.

Price Growth

GBIO (@Biotechnology) experienced а -13.00% price change this week, while GLSI (@Biotechnology) price change was -13.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

GBIO is expected to report earnings on May 01, 2025.

GLSI is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($122M) has a higher market cap than GBIO($26.6M). GLSI YTD gains are higher at: -17.631 vs. GBIO (-62.500). GLSI has higher annual earnings (EBITDA): -10.76M vs. GBIO (-74.26M). GBIO has more cash in the bank: 185M vs. GLSI (5.82M). GBIO has higher revenues than GLSI: GBIO (19.9M) vs GLSI (0).
GBIOGLSIGBIO / GLSI
Capitalization26.6M122M22%
EBITDA-74.26M-10.76M690%
Gain YTD-62.500-17.631354%
P/E RatioN/AN/A-
Revenue19.9M0-
Total Cash185M5.82M3,178%
Total Debt93.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
GBIOGLSI
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 19 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMCFX27.29N/A
N/A
GMO International Equity IV
LVORX16.80N/A
N/A
Lord Abbett Value Opportunities R3
FSCNX15.25N/A
N/A
Fidelity Advisor Asset Manager 60% C
NSNAX43.92N/A
N/A
Neuberger Berman Small Cap Growth A
ECFGX20.86N/A
N/A
Eaton Vance Focused Growth Opps C

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+7.37%
ABOS - GBIO
49%
Loosely correlated
-8.52%
ATNM - GBIO
46%
Loosely correlated
-8.55%
AURA - GBIO
45%
Loosely correlated
-3.87%
FHTX - GBIO
44%
Loosely correlated
-7.89%
ATOS - GBIO
43%
Loosely correlated
-6.56%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with DNLI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-1.07%
DNLI - GLSI
39%
Loosely correlated
-6.91%
ABOS - GLSI
36%
Loosely correlated
-8.52%
GBIO - GLSI
36%
Loosely correlated
+7.37%
ATXS - GLSI
35%
Loosely correlated
-6.70%
SCPH - GLSI
35%
Loosely correlated
-8.00%
More